Pulse Biosciences, Inc. (PLSE) SEC Filing 8-K Material Event for the period ending Thursday, April 14, 2022

Pulse Biosciences, Inc.

CIK: 1625101 Ticker: PLSE

View differences made from one to another to evaluate Pulse Biosciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Pulse Biosciences, Inc..


Assess how Pulse Biosciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Pulse Biosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Pulse Biosciences, Inc. provided additional information to their SEC Filing as exhibits

Ticker: PLSE
CIK: 1625101
Form Type: 8-K Corporate News
Accession Number: 0001625101-22-000027
Submitted to the SEC: Thu Apr 14 2022 4:23:52 PM EST
Accepted by the SEC: Thu Apr 14 2022
Period: Thursday, April 14, 2022
Industry: Surgical And Medical Instruments And Apparatus
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: